
Annual blood test for cancer could stop half of cases reaching advanced stage
Researchers writing in the journal BMJ Open say screening people annually - or every two years - could boost early detection and stop cancers reaching the stage where treatments fail
Research suggests that an annual blood test for the earliest signs of cancer could prevent approximately half of all cases from reaching an advanced stage.
Scientists are currently investigating whether these simple blood tests can effectively detect cancer before symptoms manifest and if they enhance survival rates.
The NHS is presently conducting trials of such tests, including the Galleri test and miONCO-Dx test. Health experts predict that a nationwide rollout of a universal cancer screening test could be less than ten years away.
According to a study published in the BMJ Open journal, researchers suggest that screening individuals annually or biennially could enhance early detection and prevent cancers from progressing to stages where treatments are ineffective.
The researchers used mathematical modelling to examine how a multi-cancer blood test would impact a group of individuals aged between 50 and 79. They considered both fast-growing tumours, which remain at stage I for two to four years before progressing, and fast aggressive tumours, which stay at stage I for one to two years before advancing.
The types of cancer studied included bladder, breast, cervical, bowel, kidney, liver and bile-duct, lung, ovarian, pancreatic, prostate, skin and blood cancers such as leukaemia.
The analysis concluded that universal cancer screening with a blood test improved early detection compared to standard care.
How would an annual test work?
More frequent screening using the fast tumour growth scenario has shown a significantly greater incidence of cancer detection compared to standard care – an additional 370 cases caught per year for every 100,000 people screened.
This resulted in a notable decrease in late-stage diagnoses by 49 per cent and a 21 per cent drop in deaths within five years when compared with patients receiving usual care.
Biennial screening, while still beneficial, didn't measure up to yearly checks – detecting 292 more instances of cancer annually per 100,000 individuals screened against standard practices.
There was also a reduction of 39 per cent in advanced-stage cancer diagnoses and a 17 per cent decrease in mortalities within the same time frame.
The study deduced that undergoing a blood test every one or two years could potentially catch 31–49 per cent of cancers at early stages (I-II) which would otherwise only be identified at later stages (III-IV).
Why is it being trialled?
Lead author on the Galleri trial and Queen Mary University of London's professor of cancer epidemiology, Peter Sasieni expressed his optimism to PA news agency: "I am very excited about the science behind these tests, but we need to ensure that the technological game-changer translates to clinical benefit."
He highlighted the necessity of their extensive randomised controlled trial: "That is why we are conducting a huge randomised controlled trial to see whether the prediction made by this modelling is reasonably accurate."
Sasieni marveled at the progress in the field: "The advances in molecular biology and artificial intelligence means that we are now able to find tiny fragments of many cancers in a small blood sample. That is incredible.
"We need to show that using these tests in people without symptoms can help identify cancers earlier when they can be successfully treated, thereby preventing advanced cancer and reducing the numbers dying from cancer."
Prof Sasieni expressed his optimism, saying he hopes that "by 2032, there should be sufficient evidence to say categorically how many lives can be saved by annual screening"
"That could lead to national rollout being completed within the next 10 years."
He also mentioned that with annual screening, the NHS should be in a position to negotiate "a much better price per test" with manufacturers compared to biennial screenings.
The NHS is expected to handle an additional 15 million blood tests annually with this new technology, which represents about a 2.5 per cent increase over current levels, but Prof Sasieni believes this will not pose a problem.
How will this impact cancer survival?
Dr David Crosby, head of prevention and early detection research at Cancer Research UK, commented: "Multi-cancer early detection (MCED) tests are a promising area of cancer research that could help clinicians diagnose cancers earlier, potentially helping more people survive cancer and live longer, better lives.
"It is encouraging that the modelling from this research predicts that annual screening with an MCED test could reduce deaths from cancer.
"However, as with any new clinical innovation, large-scale clinical trials and independent reviews are needed to fully assess the benefits and risks of using MCED tests in the clinic.
"With many researchers and companies active in the cancer early detection space and a range of tests available, we want to see Government and NHS support for a wide range of research.
"That way, we can maximise the chances of finding tests that improve cancer outcomes and make a meaningful difference to patients."
Last month, the Department of Health unveiled a trial within the NHS involving the miONCO-Dx blood test, which will be used on a cohort of 8,000 patients.
The innovative test scrutinises the microRNA from a blood sample and employs artificial intelligence to ascertain the presence of cancer, as well as pinpointing its location within the body.
Initial assessments indicate that the test has the capability to detect up to 12 common types of cancer.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
an hour ago
- The Independent
The NHS will receive £6bn in funding. Here's how it will be used
Rachel Reeves has pledged a £6bn investment to accelerate NHS tests and treatments, following substantial budget increases. The funding aims to provide new scanners, ambulances, and urgent treatment centres, delivering up to four million more tests and procedures in five years. This investment supports the government's goal of reducing NHS waiting lists in England, with Labour aiming for 92 per cent of routine operations to be carried out within 18 weeks. Health Secretary Wes Streeting said the investment will generate millions more diagnostic tests, scans, and procedures, building on 3.6 million extra elective care appointments already delivered. Health leaders are sceptical, with Matthew Taylor of the NHS Confederation warning that the £29bn increase may not cover rising costs and guarantee waiting time targets, while Sarah Woolnough of the King's Fund questions how all NHS needs can be met with this settlement alone.

Leader Live
2 hours ago
- Leader Live
MS for Delyn provides several updates in this weeks column
MS for Delyn Last week in the Senedd, I paid tribute to those at the heart of our communities during Volunteers Week – volunteers, groups and organisers who work tirelessly behind the scenes. Whether it's Mold Community Clubhouse & Gardens, hospital leagues of friends or Walk & Talk Today in Ffynnongroyw, their work matters and makes a difference – and, during Pride Month, let's also celebrate the people powering our local Pride events, such as the first ever Flint Pride last year and Prestatyn Pride last weekend. In the Senedd debate, I called on the Welsh Government to build on its support for volunteers not just with funding, but through creative partnerships that help more people get involved. You watch all my questions in the Senedd on my Facebook page at The NHS matters to us all. Last week in the Senedd I talked about the challenges that remain for Betsi Cadwaladr University Health Board, but also the positive progress that we are seeing being made – two-year waits are down by 67 per cent over the last three years, more than 12,000 patients have come off the two-year wait list and the new Llandudno orthopaedic hub is on track to make a difference when that opens later this year. This demonstrates the difference additional funding makes, thanks to having two Labour governments working together. But investment alone isn't enough, it also takes system change and that won't work without our incredible NHS workforce. That's why during a debate in the Senedd last week, I called for reassurance that staff on the ground will be fully supported and involved in shaping the improvements we all want to see. NHS staff are key to turning around the health board – I am hopeful that we are heading in the right direction, but of course there is a lot more work to do. It was a real pleasure last week to attend the North Wales Police and Crime Commissioner Community Awards ceremony on Thursday evening. The awards recognise individuals and organisations who are making a difference and making life better for victims, for communities and supporting the police in their work right across North Wales. It was especially lovely to see the work of Louise Rudd and Heather Williams and all the team at Walk & Talk Today in Ffynnongroyw rightly recognised in the Community Champion Award. A few years back now, I joined them at the opening of their first premises and, since then, I've seen them go from strength to strength, making a real and lasting difference to the village and surrounding area. Llongyfarchiadau Walk & Talk Today! Regular readers will know that I'm passionate about amplifying young people's voices – young people are truly the future of Wales and politicians aren't always good at listening to what they have to say. Here in Wales, we have the Welsh Youth Parliament which gives young people the chance to represent their communities from their own perspectives and recently I discovered a podcast entitled 'Get Informed and Get Involved', which has been made by the Youth Voice Network for Wales. If you like podcasts, it's worth a listen – the young presenters tackle how young people can navigate social media, how to tell the difference between reliable information and misinformation and give tips on how to get involved in democracy. I recently met with campaigners from the League Against Cruel Sports and Animal Aid to discuss the urgent need to end the caged breeding of game birds in Wales. Every year, tens of thousands of pheasants and partridges are kept in tiny, wire-mesh cages and are denied the ability to move freely. There are currently no specific regulations protecting these birds and no routine inspections of game bird farms in Wales – despite public opposition and clear welfare concerns, progress has stalled for years. Residents from across my constituency have been in touch about this issue asking for real action. Wales must follow through on its commitments to animal welfare and ban cages for breeding game birds. Finally, I had the chance on Friday to visit Theatr Clwyd to see Tick, Tick… Boom, the first performance in the newly-transformed theatre which will run until June 28 – the venue is operating a phased return so that it could stay open longer during the building work. The transformation was made possible with support from Flintshire County Council, the Arts Council of Wales and £22m of Welsh Government funding and I have to say it's a stunning building which will continue to serve our communities here in North East Wales for many years to come – the new-look theatre, restaurant, community facilities and landscaped areas around it will make the theatre even more of an asset to our area. As always, if you would like advice and/or support, please don't hesitate to get in touch on any of the following contact details – 52 High Street, Mold, Flintshire, on 01352 753464 or by email You can also keep up to date via my Facebook page – Constituents are, of course, welcome to contact my office to arrange an appointment to see me, you don't need to wait for an advice surgery.


The Independent
7 hours ago
- The Independent
Chancellor unveils £6bn NHS funding after health-centred spending review
Some £6 billion will be spent on speeding up testing and treatment in the NHS, Rachel Reeves has announced, after she placed the health service at the heart of Government spending plans. The Chancellor unveiled the investment, which includes new scanners, ambulances and urgent treatment centres aimed at providing an extra four million appointments in England over the next five years, after Wednesday's spending review. The funding is aimed at reducing waiting lists and reaching Labour's 'milestone' of ensuring the health service carries out 92% of routine operations within 18 weeks. In the review, Ms Reeves set out day-to-day spending across Government for the next three years, as well as plans for capital investment over the next four years. The NHS and defence were seen as the winners from the settlement, as both will see higher than average rises in public spending. This comes at cost of squeezing the budgets of other Whitehall departments and experts have warned tax rises may be needed later this year. The Chancellor and Sir Keir Starmer both sought to portray the review as a 'new phase' for the Government, following the criticism Labour has faced during its first year in power, including over cuts to winter fuel allowance. Ms Reeves claimed the NHS had been 'put on its knees' as a result of under-investment by the previous government, adding: 'We are investing in Britain's renewal, and we will turn that around.' The new £6 billion investment will come from the capital settlement for the NHS and will also help to speed up diagnoses with scans and treatment available in places such as shopping centres and high streets. The scale of day-to-day spending for the NHS is akin to an extra £29 billion a year. In a broadcast interview on Wednesday evening, Ms Reeves said the Government was 'confident' it could meet its pledge to reduce waiting lists after the boost to NHS spending. But while health and defence have benefited from the review, the Home Office, Ministry of Housing, Communities and Local Government, Department for Culture, Media and Sport, Department for Transport and Department for the Environment, Food and Rural Affairs are all in line for real-terms cuts in day-to-day spending. The Foreign Office is also in line for real-terms cuts, mainly as a result of a reduction in the overseas aid budget, which was slashed as part of the commitment to boost defence spending to 2.6% of gross domestic product – including the intelligence agencies – from 2027. Ms Reeves acknowledged 'not everyone has been able to get exactly what they want' following Cabinet squabbling over departmental budgets. She said 'every penny' of the spending increases had been funded through the tax and borrowing changes she had announced in her first budget. The Chancellor also insisted she would not need to mount another tax raid to pay for her plans, but experts warned the money for the NHS might still not be enough and the Government is under international pressure to boost defence funding further. Paul Johnson, of the Institute for Fiscal Studies, described the hospital waiting times target as 'enormously ambitious', adding: 'And on defence, it's entirely possible that an increase in the Nato spending target will mean that maintaining defence spending at 2.6% of GDP no longer cuts the mustard.' At a summit later this month Nato members will consider calls to increase spending to 3.5% on defence, with a future 1.5% on defence-related measures. Steven Millard, interim director of the NIESR economic research institute, said the Chancellor's non-negotiable fiscal rules, coupled with the 'small amount of headroom' in her spending plans, meant 'it is now almost inevitable that if she is to keep to her fiscal rules, she will have to raise taxes in the autumn budget'. Elsewhere, policing leaders warned forces may need to make deep cuts after their settlement was announced. The spending review provides more than £2 billion for forces, but ministers have acknowledged some of that 'spending power' will come from council tax hikes.